Effect of Intravitreal Anti-Endothelial Growth Factor Agents on Renal Function in Patients With Diabetes Mellitus

Effect of Intravitreal Anti-Endothelial Growth Factor Agents on Renal Function in Patients With Diabetes Mellitus

Introduction: Intravitreal administration of vascular endothelial growth factor inhibitors (anti-VEGF) is the treatment of choice in retinal pathology associated with type 2 diabetes mellitus (DM2). We aimed to analyze the effect of intravitreal anti-VEGF administration on renal function in patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Marta Rivero, María Fernández-Vidal, Justo Sandino, Raquel Berzal Rico, Candela Moliz, José Enrique Ruiz-Cabello, Lucía Cordero Garcia-Galán, Celia González-García, Paúl Hernández-Velasco, Julián Segura, Eduardo Gutiérrez, Enrique Morales
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Kidney International Reports
Subjects:
anti-VEGF
diabetes mellitus
proteinuria
renal function
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924000925
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items